Inspire Medical Systems Shares Jump After Wells Fargo Upgrade, Q3 Beat

MT Newswires Live
Nov 05

Inspire Medical Systems (INSP) shares jumped about 15% in recent Tuesday trading after Wells Fargo upgraded the stock following better-than-expected Q3 results.

Wells Fargo upgraded the stock to overweight from equalweight and adjusted its price target to $90 per share from $101.

Inspire Medical Systems reported Q3 adjusted earnings late Monday of $0.38 per diluted share, down from $0.60 a year earlier. Analysts polled by FactSet expected a loss of $0.19.

Revenue for the three months ended Sept. 30 was $224.5 million, up from $203.2 million a year earlier. Analysts surveyed by FactSet expected $220.4 million.

The company now expects full-year 2025 diluted EPS of $0.90 to $1, versus $0.40 to $0.50 earlier. Analysts surveyed by FactSet expect EPS of $0.77.

The company maintained its 2025 revenue guidance of $900 million to $910 million. Analysts surveyed by FactSet expect $906.4 million.

Price: 84.75, Change: +11.04, Percent Change: +14.98

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10